Article ID Journal Published Year Pages File Type
8744951 Clinical Microbiology and Infection 2018 12 Pages PDF
Abstract
With the exception of VEGF-targeted agents, the overall risk of infection associated with the reviewed therapies seems to be low.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Microbiology
Preview
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)
Authors
, , , , ,